MILLER, Mark Thomas,ANDERSON, Corey,ARUMUGAM, Vijayalaksmi,BEAR, Brian Richard,BINCH, Hayley Marie,CLEMENS, Jeremy J.,CLEVELAND, Thomas,CONROY, Erica,COON, Timothy Richard,FRIEMAN, Bryan A.,GROOTENHUI
申请号：
DK15849396
公开号：
DK3203840T3
申请日:
2015.10.06
申请国别(地区):
DK
年份:
2020
代理人:
摘要：
The present invention features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R1, R2, R3, W, X, Y, Z, n, o, p, and q are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present invention also features pharmaceutical compositions, method of treating, and kits thereof.
